Frontlight ResearchEarly access
Trial site
Accellacare Research of Winston Salem
- 1running trial
- 5closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Obesity3 trials
- Alzheimer disease2 trials
- Osteoarthritis1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 23 trials
- Phase 33 trials
- Status
- Completed3 trials
- Terminated2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Cassava Sciences, Inc.2 trials
- Hoffmann-La Roche2 trials
- Carmot Therapeutics, Inc.1 trial
- Grünenthal GmbH1 trial
Running trials
Closed trials
Completed
Completed
Terminated
Open-label Extension for Phase 3 Clinical Trials of Simufilam
Completed
Terminated
Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease
Site data: ClinicalTrials.govUpdated 13 Nov 2026